Back to search

Article

Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemia

2022-10-19

Abstract excerpt

<h4>Background: </h4> The status of minimal residual disease (MRD) has been established as an important prognostic indicator in chronic lymphocytic leukemia (CLL). Methods Owing to the requirements of high accuracy, reproducibility and comparability of MRD, this study investigated the performance of a flow cytometric approach (CD45-ROR1 panel) in the MRD detection of CLL patients, with European Research Initiativ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37f7238e-4942-5c99-a94e-fbbe6a892257
DOI
10.21203/rs.3.rs-2170705/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemiaDOI 10.21203/rs.3.rs-2170705/v1
Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8‐color flow cytometry protocol in routine hematological practiceSemantic proximity
Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR.Semantic proximity
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.Semantic proximity
Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic LeukemiaSemantic proximity
Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity
Prognostic and Therapeutic Implications of Measurable Residual Disease Detection Across Hematologic Malignancies: Clinical Impact on Relapse Prediction and Survival OutcomesSemantic proximity
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantationSemantic proximity
Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemiaSemantic proximity
Novel microfluidic device for measurable residual disease detection in acute leukemiaSemantic proximity
MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.Semantic proximity
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid LeukemiaSemantic proximity
Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLLSemantic proximity
Select a neighboring publication to make it the new centre.